C4Diagnostics has successfully reached several key milestones in the beginning of 2019: after its ISO13485 certification in January 2019, C4Diagnostics has secured its first product introduction on the market by entering into exclusive distribution agreements with key stakeholders, including Eurobio Scientific (France), Ventmed (United Kingdom) and BestBion Dx (Germany and Austria).
